Madam Speaker, the member is correct. Canada should always and will always need to be open to talking and working with international partners on precisely that topic of TRIPS and the patent-related agenda.
However, in relation to the previous question, I am going to add that Canada committed 200 million doses of vaccines in 2020, and half of those vaccines have already been delivered.
In addition, we committed to $2.5 billion in additional assistance, because it is not only the vaccine product itself that is needed, but also the technology, the infrastructure, the health care resources and the communication campaign where there is vaccine hesitancy. Therefore, it is a combination of being strong on the products, being strong on the international agenda and being strong on the supports that are needed to make sure that everyone in the world gets vaccinated and is protected against this serious disease.